428 related articles for article (PubMed ID: 9420244)
1. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
[TBL] [Abstract][Full Text] [Related]
2. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
3. Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.
Morello CS; Ye M; Hung S; Kelley LA; Spector DH
J Virol; 2005 Jan; 79(1):159-75. PubMed ID: 15596812
[TBL] [Abstract][Full Text] [Related]
4. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
Morello CS; Ye M; Spector DH
J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
[TBL] [Abstract][Full Text] [Related]
5. Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus.
Gopal IN; Quinn A; Henry SC; Hamilton JD; Staats HF; Frothingham R
Microbiol Immunol; 2005; 49(2):113-9. PubMed ID: 15722596
[TBL] [Abstract][Full Text] [Related]
6. Immunisation of Balb/c mice with severely attenuated murine cytomegalovirus mutants induces protective cellular and humoral immunity.
Morley PJ; Ertl P; Sweet C
J Med Virol; 2002 Jun; 67(2):187-99. PubMed ID: 11992579
[TBL] [Abstract][Full Text] [Related]
7. Protective MCMV immunity by vaccination of the salivary gland via Wharton's duct: replication-deficient recombinant adenovirus expressing individual MCMV genes elicits protection similar to that of MCMV.
Liu G; Zhang F; Wang R; London L; London SD
FASEB J; 2014 Apr; 28(4):1698-710. PubMed ID: 24391133
[TBL] [Abstract][Full Text] [Related]
8. Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism.
Cavanaugh VJ; Stenberg RM; Staley TL; Virgin HW; MacDonald MR; Paetzold S; Farrell HE; Rawlinson WD; Campbell AE
J Virol; 1996 Mar; 70(3):1365-74. PubMed ID: 8627652
[TBL] [Abstract][Full Text] [Related]
9. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.
Presti RM; Pollock JL; Dal Canto AJ; O'Guin AK; Virgin HW
J Exp Med; 1998 Aug; 188(3):577-88. PubMed ID: 9687534
[TBL] [Abstract][Full Text] [Related]
10. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
Ye M; Morello CS; Spector DH
J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
[TBL] [Abstract][Full Text] [Related]
11. Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge.
Zheng X; Oduro JD; Boehme JD; Borkner L; Ebensen T; Heise U; Gereke M; Pils MC; Krmpotic A; Guzmán CA; Bruder D; Čičin-Šain L
PLoS Pathog; 2019 Sep; 15(9):e1008036. PubMed ID: 31525249
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cell-mediated dissemination of murine cytomegalovirus is regulated by NK cells and immune evasion.
Zhang S; Springer LE; Rao HZ; Espinosa Trethewy RG; Bishop LM; Hancock MH; Grey F; Snyder CM
PLoS Pathog; 2021 Jan; 17(1):e1009255. PubMed ID: 33508041
[TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.
Cicin-Sain L; Bubić I; Schnee M; Ruzsics Z; Mohr C; Jonjić S; Koszinowski UH
J Virol; 2007 Dec; 81(24):13825-34. PubMed ID: 17913824
[TBL] [Abstract][Full Text] [Related]
15. Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge.
Ye M; Morello CS; Spector DH
J Virol; 2002 Mar; 76(5):2100-12. PubMed ID: 11836387
[TBL] [Abstract][Full Text] [Related]
16. An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV.
Wang H; Yao Y; Huang C; Fu X; Chen Q; Zhang H; Chen J; Fang F; Xie Z; Chen Z
BMC Infect Dis; 2014 Apr; 14():195. PubMed ID: 24720840
[TBL] [Abstract][Full Text] [Related]
17. DNA immunization confers protection against murine cytomegalovirus infection.
González Armas JC; Morello CS; Cranmer LD; Spector DH
J Virol; 1996 Nov; 70(11):7921-8. PubMed ID: 8892915
[TBL] [Abstract][Full Text] [Related]
18. An attenuated temperature-sensitive strain of cytomegalovirus (tsm5) establishes immunity without development of CD8(+) T cell memory inflation.
Beswick M; Pachnio A; Al-Ali A; Sweet C; Moss PA
J Med Virol; 2013 Nov; 85(11):1968-74. PubMed ID: 23852921
[TBL] [Abstract][Full Text] [Related]
19. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection.
Lathbury LJ; Allan JE; Shellam GR; Scalzo AA
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2605-13. PubMed ID: 8887497
[TBL] [Abstract][Full Text] [Related]
20. Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection.
Oduro JD; Redeker A; Lemmermann NAW; Ebermann L; Marandu TF; Dekhtiarenko I; Holzki JK; Busch DH; Arens R; Čičin-Šain L
J Gen Virol; 2016 Jan; 97(1):185-195. PubMed ID: 26555192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
